140 related articles for article (PubMed ID: 20146812)
1. Identification of lung cancer with high sensitivity and specificity by blood testing.
Leidinger P; Keller A; Heisel S; Ludwig N; Rheinheimer S; Klein V; Andres C; Staratschek-Jox A; Wolf J; Stoelben E; Stephan B; Stehle I; Hamacher J; Huwer H; Lenhof HP; Meese E
Respir Res; 2010 Feb; 11(1):18. PubMed ID: 20146812
[TBL] [Abstract][Full Text] [Related]
2. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J
Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790
[TBL] [Abstract][Full Text] [Related]
3. The effect of artificial neural network model combined with six tumor markers in auxiliary diagnosis of lung cancer.
Feng F; Wu Y; Wu Y; Nie G; Ni R
J Med Syst; 2012 Oct; 36(5):2973-80. PubMed ID: 21882004
[TBL] [Abstract][Full Text] [Related]
4. Panel of serum biomarkers for the diagnosis of lung cancer.
Patz EF; Campa MJ; Gottlin EB; Kusmartseva I; Guan XR; Herndon JE
J Clin Oncol; 2007 Dec; 25(35):5578-83. PubMed ID: 18065730
[TBL] [Abstract][Full Text] [Related]
5. Serum calprotectin, CD26 and EGF to establish a panel for the diagnosis of lung cancer.
Blanco-Prieto S; Vázquez-Iglesias L; Rodríguez-Girondo M; Barcia-Castro L; Fernández-Villar A; Botana-Rial MI; Rodríguez-Berrocal FJ; de la Cadena MP
PLoS One; 2015; 10(5):e0127318. PubMed ID: 25992884
[TBL] [Abstract][Full Text] [Related]
6. Comparative evaluation of support vector machines for computer aided diagnosis of lung cancer in CT based on a multi-dimensional data set.
Sun T; Wang J; Li X; Lv P; Liu F; Luo Y; Gao Q; Zhu H; Guo X
Comput Methods Programs Biomed; 2013 Aug; 111(2):519-24. PubMed ID: 23727300
[TBL] [Abstract][Full Text] [Related]
7. Triple test with tumor markers CYFRA 21.1, HE4, and ProGRP might contribute to diagnosis and subtyping of lung cancer.
Korkmaz ET; Koksal D; Aksu F; Dikmen ZG; Icen D; Maden E; Onder S; Akbiyik F; Emri S
Clin Biochem; 2018 Aug; 58():15-19. PubMed ID: 29729229
[TBL] [Abstract][Full Text] [Related]
8. Panels of tumor-derived RNA markers in peripheral blood of patients with non-small cell lung cancer: their dependence on age, gender and clinical stages.
Chian CF; Hwang YT; Terng HJ; Lee SC; Chao TY; Chang H; Ho CL; Wu YY; Perng WC
Oncotarget; 2016 Aug; 7(31):50582-50595. PubMed ID: 27418131
[TBL] [Abstract][Full Text] [Related]
9. Blinded Validation of Breath Biomarkers of Lung Cancer, a Potential Ancillary to Chest CT Screening.
Phillips M; Bauer TL; Cataneo RN; Lebauer C; Mundada M; Pass HI; Ramakrishna N; Rom WN; Vallières E
PLoS One; 2015; 10(12):e0142484. PubMed ID: 26698306
[TBL] [Abstract][Full Text] [Related]
10. A novel ensemble strategy for classification of prostate cancer protein mass spectra.
Assareh A; Moradi MH; Esmaeili V
Annu Int Conf IEEE Eng Med Biol Soc; 2007; 2007():5988-91. PubMed ID: 18003378
[TBL] [Abstract][Full Text] [Related]
11. Whole blood microRNA expression may not be useful for screening non-small cell lung cancer.
Patnaik SK; Kannisto ED; Mallick R; Vachani A; Yendamuri S
PLoS One; 2017; 12(7):e0181926. PubMed ID: 28742859
[TBL] [Abstract][Full Text] [Related]
12. Rethinking Autoantibody Signature Panels for Cancer Diagnosis.
Campa MJ; Gottlin EB; Herndon JE; Patz EF
J Thorac Oncol; 2017 Jun; 12(6):1011-1014. PubMed ID: 28126538
[TBL] [Abstract][Full Text] [Related]
13. Highly Sensitive Marker Panel for Guidance in Lung Cancer Rapid Diagnostic Units.
Blanco-Prieto S; De Chiara L; Rodríguez-Girondo M; Vázquez-Iglesias L; Rodríguez-Berrocal FJ; Fernández-Villar A; Botana-Rial MI; de la Cadena MP
Sci Rep; 2017 Jan; 7():41151. PubMed ID: 28117344
[TBL] [Abstract][Full Text] [Related]
14. Fusion of quantitative imaging features and serum biomarkers to improve performance of computer-aided diagnosis scheme for lung cancer: A preliminary study.
Gong J; Liu JY; Jiang YJ; Sun XW; Zheng B; Nie SD
Med Phys; 2018 Dec; 45(12):5472-5481. PubMed ID: 30317652
[TBL] [Abstract][Full Text] [Related]
15. Sensitive assays for detection of lung cancer. Molecular markers in blood samples.
Fournier MV; Martin KJ; Graner E; Pardee AB
Methods Mol Med; 2003; 75():239-50. PubMed ID: 12407744
[No Abstract] [Full Text] [Related]
16. Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets.
Best MG; Sol N; In 't Veld SGJG; Vancura A; Muller M; Niemeijer AN; Fejes AV; Tjon Kon Fat LA; Huis In 't Veld AE; Leurs C; Le Large TY; Meijer LL; Kooi IE; Rustenburg F; Schellen P; Verschueren H; Post E; Wedekind LE; Bracht J; Esenkbrink M; Wils L; Favaro F; Schoonhoven JD; Tannous J; Meijers-Heijboer H; Kazemier G; Giovannetti E; Reijneveld JC; Idema S; Killestein J; Heger M; de Jager SC; Urbanus RT; Hoefer IE; Pasterkamp G; Mannhalter C; Gomez-Arroyo J; Bogaard HJ; Noske DP; Vandertop WP; van den Broek D; Ylstra B; Nilsson RJA; Wesseling P; Karachaliou N; Rosell R; Lee-Lewandrowski E; Lewandrowski KB; Tannous BA; de Langen AJ; Smit EF; van den Heuvel MM; Wurdinger T
Cancer Cell; 2017 Aug; 32(2):238-252.e9. PubMed ID: 28810146
[TBL] [Abstract][Full Text] [Related]
17. Qualification and Verification of Serological Biomarker Candidates for Lung Adenocarcinoma by Targeted Mass Spectrometry.
Wu HY; Goan YG; Chang YH; Yang YF; Chang HJ; Cheng PN; Wu CC; Zgoda VG; Chen YJ; Liao PC
J Proteome Res; 2015 Aug; 14(8):3039-50. PubMed ID: 26120931
[TBL] [Abstract][Full Text] [Related]
18. Prediction of lung cancer based on serum biomarkers by gene expression programming methods.
Yu Z; Chen XZ; Cui LH; Si HZ; Lu HJ; Liu SH
Asian Pac J Cancer Prev; 2014; 15(21):9367-73. PubMed ID: 25422226
[TBL] [Abstract][Full Text] [Related]
19. A novel detection method of non-small cell lung cancer using multiplexed bead-based serum biomarker profiling.
Lee HJ; Kim YT; Park PJ; Shin YS; Kang KN; Kim Y; Kim CW
J Thorac Cardiovasc Surg; 2012 Feb; 143(2):421-7. PubMed ID: 22104668
[TBL] [Abstract][Full Text] [Related]
20. Fusion of Quantitative Image and Genomic Biomarkers to Improve Prognosis Assessment of Early Stage Lung Cancer Patients.
Emaminejad N; Qian W; Guan Y; Tan M; Qiu Y; Liu H; Zheng B
IEEE Trans Biomed Eng; 2016 May; 63(5):1034-1043. PubMed ID: 26390440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
